Clinical Trial Update: Fixed-dose Activated Versus Variable-dose Inactivated Prothrombin Complex Concentrate for Warfarin-associated Major Bleed

View source ↗

Summary

This clinical trial update reports the completion of a study comparing fixed-dose activated prothrombin complex concentrate to variable-dose inactivated prothro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Warfarin-associated Major Hemorrhage

Drugs mentioned

• FEIBA (activated prothrombin complex concentrate)
• KCENTRA

Snippet

Sponsor: Rush University Medical Center | Conditions: Hemorrhage | Status: COMPLETED